Inhibition of histone deacetylase by butyrate protects rat liver from ischemic reperfusion injury

International Journal of Molecular Sciences

Volumn 15, Issue 11, 2014, Pages 21069-21079

  Sun, Jie ^a   Wu, Qiujv ^a   Sun, Huiling ^a   Qiao, Yingli ^a  

^a LIAOCHENG PEOPLE'S HOSPITAL   (China)

Author keywords

Butyrate; Histone acetylation; Histone deacetylase; Reperfusion injury

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BUTYRIC ACID; HEAT SHOCK PROTEIN 70; HISTONE DEACETYLASE; HISTONE H3; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MYELOPEROXIDASE; TUMOR NECROSIS FACTOR ALPHA; BUTYRIC ACID DERIVATIVE; HISTONE; HISTONE DEACETYLASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; HISTOLOGY; HISTONE ACETYLATION; HISTOPATHOLOGY; LIVER NECROSIS; LIVER PROTECTION; MALE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; UPREGULATION; WESTERN BLOTTING; ACETYLATION; ANIMAL; DRUG EFFECTS; LIVER; LIVER DISEASES; METABOLISM; PATHOLOGY; SPRAGUE DAWLEY RAT;

RATTUS;

ACETYLATION; ANIMALS; BUTYRATES; HISTONE DEACETYLASE INHIBITORS; HISTONE DEACETYLASES; HISTONES; HSP70 HEAT-SHOCK PROTEINS; LIVER; LIVER DISEASES; MALE; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY;

EID: 84910135562     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms151121069     Document Type: Article

References (26)

1. Foley, D.P.; Fernandez, L.A.; Leverson, G.; Chin, L.T.; Krieger, N.; Cooper, J.T.; Shames, B.D.; Becker, Y.T.; Odorico, J.S.; Knechtle, S.J., et al. Donation after cardiac death: The University of Wisconsin experience with liver transplantation. Ann. Surg. 2005, 242, 724-731.
2. Reich, D.J.; Hong, J.C. Current status of donation after cardiac death liver transplantation. Curr. Opin. Organ Transplant. 2010, 15, 316-321.
3. Tsung, A.; Sahai, R.; Tanaka, H.; Nakao, A.; Fink, M.P.; Lotze, M.T.; Yang, H.; Li, J.; Tracey, K.J.; Geller, D.A., et al. The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion. J. Exp. Med. 2005, 201, 1135-1143.
4. Wu, C.; Wang, P.; Rao, J.; Wang, Z.; Zhang, C.; Lu, L.; Zhang, F. Triptolide alleviates hepatic ischemia/reperfusion injury by attenuating oxidative stress and inhibiting NF-κB activity in mice. J. Surg. Res. 2011, 166, e205-e213.
5. Formisano, L.; Noh, K.M.; Miyawaki, T.; Mashiko, T.; Bennett, M.V.; Zukin, R.S. Ischemic insults promote epigenetic reprogramming of mu opioid receptor expression in hippocampal neurons. Proc. Natl. Acad. Sci. USA 2007, 104, 4170-4175.
6. Mehta, T.K.; Hoque, M.O.; Ugarte, R.; Rahman, M.H.; Kraus, E.; Montgomery, R.; Melancon, K.; Sidransky, D.; Rabb, H. Quantitative detection of promoter hypermethylation as a biomarker of acute kidney injury during transplantation. Transplant. Proc. 2006, 38, 3420-3426.
7. Granger, A.; Abdullah, I.; Huebner, F.; Stout, A.; Wang, T.; Huebner, T.; Epstein, J.A.; Gruber, P.J. Histone deacetylase inhibition reduces myocardial ischemia-reperfusion injury in mice. FASEB J. 2008, 22, 3549-3560.
8. Heightman, T.D. Therapeutic prospects for epigenetic modulation. Expert Opin. Ther. Targets 2011, 15, 729-740.
9. Halili, M.A.; Andrews, M.R.; Sweet, M.J.; Fairlie, D.P. Histone deacetylase inhibitors in inflammatory disease. Curr. Top. Med. Chem. 2009, 9, 309-319.
10. Cook, S.I.; Sellin, J.H. Review article: Short chain fatty acids in health and disease. Aliment. Pharmacol. Ther. 1998, 12, 499-507.
11. Canani, R.B.; Costanzo, M.D.; Leone, L.; Pedata, M.; Meli, R.; Calignano, A. Potential beneficial effects of butyrate in intestinal and extraintestinal diseases. World J. Gastroenterol. 2011, 17, 1519-1528.
12. Qiao, Y.L.; Qian, J.M.; Wang, F.R.; Ma, Z.Y.; Wang, Q.W. Butyrate protects liver against ischemia reperfusion injury by inhibiting nuclear factor κB activation in Kupffer cells. J. Surg. Res. 2014, 187, 653-659.
13. Liu, B.; Qian, J.; Wang, Q.; Wang, F.; Ma, Z.; Qiao, Y. Butyrate protects rat liver against total hepatic ischemia reperfusion injury with bowel congestion. PLoS One 2014, 9, e106184.
14. Kim, H.J.; Rowe, M.; Ren, M.; Hong, J.S.; Chen, P.S.; Chuang, D.M. Histone deacetylase inhibitors exhibit anti-inflammatory and neuroprotective effects in a rat permanent ischemic model of stroke: Multiple mechanisms of action. J. Pharmacol. Exp. Ther. 2007, 321, 892-901.
15. Ma, Z.Y.; Qian, J.M.; Rui, X.H.; Wang, F.R.; Wang, Q.W.; Cui, Y.Y.; Peng, Z.H. Inhibition of matrix metalloproteinase-9 attenuates acute small-for-size liver graft injury in rats. Am. J. Transplant. 2010, 10, 784-795.
16. Kuboki, S.; Schuster, R.; Blanchard, J.; Pritts, T.A.; Wong, H.R.; Lentsch, A.B. Role of heat shock protein 70 in hepatic ischemia-reperfusion injury in mice. Am. J. Physiol. Gastrointest. Liver Physiol. 2007, 292, G1141-G1149.
17. Ren, M.; Leng, Y.; Jeong, M.; Leeds, P.R.; Chuang, D.M. Valproic acid reduces brain damage induced by transient focal cerebral ischemia in rats: Potential roles of histone deacetylase inhibition and heat shock protein induction. J. Neurochem. 2004, 89, 1358-1367.
18. Chen, T.; Sun, H.; Lu, J.; Zhao, Y.; Tao, D.; Li, X.; Huang, B. Histone acetylation is involved in hsp70 gene transcription regulation in Drosophila melanogaster. Arch. Biochem. Biophys. 2002, 408, 171-176.
19. Kamo, N.; Ke, B.; Ghaffari, A.A.; Shen, X.D.; Busuttil, R.W.; Cheng, G.; Kupiec-Weglinski, J.W. ASC/caspase-1/IL-1β signaling triggers inflammatory responses by promoting HMGB1 induction in liver ischemia/reperfusion injury. Hepatology 2013, 58, 351-362.
20. Yang, X.J.; Seto, E. HATs and HDACs: From structure, function and regulation to novel strategies for therapy and prevention. Oncogene 2007, 26, 5310-5318.
21. Cheung, P.; Allis, C.D.; Sassone-Corsi, P. Signaling to chromatin through histone modifications. Cell 2000, 103, 263-271.
22. Marks, P.; Rifkind, R.A.; Richon, V.M.; Breslow, R.; Miller, T.; Kelly, W.K. Histone deacetylases and cancer: Causes and therapies. Nat. Rev. Cancer 2001, 1, 194-202.
23. Evankovich, J.; Cho, S.W.; Zhang, R.; Cardinal, J.; Dhupar, R.; Zhang, L.; Klune, J.R.; Zlotnicki, J.; Billiar, T.; Tsung, A. High mobility group box 1 release from hepatocytes during ischemia and reperfusion injury is mediated by decreased histone deacetylase activity. J. Biol. Chem. 2010, 285, 39888-39897.
24. Lv, L.; Sun, Y.; Han, X.; Xu, C.C.; Tang, Y.P.; Dong, Q. Valproic acid improves outcome after rodent spinal cord injury: Potential roles of histone deacetylase inhibition. Brain Res. 2011, 1396, 60-68.
25. Zhao, Y.; Sun, H.; Lu, J.; Li, X.; Chen, X.; Tao, D.; Huang, W.; Huang, B. Lifespan extension and elevated hsp gene expression in Drosophila caused by histone deacetylase inhibitors. J. Exp. Biol. 2005, 208, 697-705.
26. Ovakim, D.H.; Heikkila, J.J. Effect of histone deacetylase inhibitors on heat shock protein gene expression during Xenopus development. Genesis 2003, 36, 88-96.